BMO Capital upgraded CenterPoint Energy (CNP) to Outperform from Market Perform with an unchanged price target of $42. The shares currently trade at an 8% premium to the group, modestly below peers with similar visible growth, the analyst tells investors in a research note. BMO believes investors will continue to favor higher growth profiles but also companies with lower regulatory and political risk this year, like CenterPoint.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNP:
- CenterPoint Energy: De‑Risked Growth, Reasonable Valuation Premium, and Attractive Risk/Reward Support Buy Rating
- CenterPoint Energy price target lowered to $43 from $45 at UBS
- CenterPoint Energy price target lowered to $36 from $39 at Morgan Stanley
- CenterPoint Energy upgraded to Overweight from Sector Weight at KeyBanc
- CenterPoint Energy price target lowered to $41 from $43 at JPMorgan